SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Jun 3, 2005
Insider Transaction Report
Form 4
Gyenes Lawrence A
SVP, Chief Financial Officer
Transactions
- Award
Common Stock, $.01 par value per share
2005-06-01+8,950→ 53,350 total
Footnotes (1)
- [F1]These shares were issued pursuant to a restricted stock grant, which vests in full on June 1, 2006. Mr. Gyenes has paid to the Company the par value of these shares.